HLS Therapeutics Inc (HLS.TO)
3.66
+0.06
(+1.67%)
CAD |
TSX |
Sep 27, 16:00
HLS Therapeutics Enterprise Value: 184.72M for Sept. 27, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
September 27, 2024 | 184.72M |
September 26, 2024 | 182.81M |
September 25, 2024 | 179.63M |
September 24, 2024 | 177.40M |
September 23, 2024 | 176.77M |
September 20, 2024 | 170.09M |
September 19, 2024 | 173.27M |
September 18, 2024 | 173.27M |
September 17, 2024 | 171.36M |
September 16, 2024 | 172.00M |
September 13, 2024 | 172.00M |
September 12, 2024 | 174.54M |
September 11, 2024 | 174.86M |
September 10, 2024 | 176.45M |
September 09, 2024 | 175.50M |
September 06, 2024 | 170.09M |
September 05, 2024 | 170.41M |
September 04, 2024 | 170.41M |
September 03, 2024 | 171.68M |
August 30, 2024 | 173.91M |
August 29, 2024 | 173.27M |
August 28, 2024 | 166.91M |
August 27, 2024 | 168.82M |
August 26, 2024 | 167.55M |
August 23, 2024 | 166.91M |
Date | Value |
---|---|
August 22, 2024 | 171.05M |
August 21, 2024 | 171.05M |
August 20, 2024 | 165.32M |
August 19, 2024 | 172.95M |
August 16, 2024 | 169.77M |
August 15, 2024 | 169.14M |
August 14, 2024 | 170.73M |
August 13, 2024 | 170.73M |
August 12, 2024 | 171.05M |
August 09, 2024 | 170.41M |
August 08, 2024 | 167.55M |
August 07, 2024 | 165.32M |
August 06, 2024 | 164.05M |
August 02, 2024 | 168.50M |
August 01, 2024 | 168.18M |
July 31, 2024 | 172.32M |
July 30, 2024 | 172.00M |
July 29, 2024 | 174.86M |
July 26, 2024 | 174.86M |
July 25, 2024 | 168.18M |
July 24, 2024 | 171.36M |
July 23, 2024 | 172.00M |
July 22, 2024 | 182.49M |
July 19, 2024 | 174.38M |
July 18, 2024 | 170.09M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
164.05M
Minimum
Aug 06 2024
850.95M
Maximum
Dec 31 2019
481.09M
Average
525.72M
Median
Enterprise Value Benchmarks
DRI Healthcare Trust | 701.03M |
Biocure Technology Inc | 0.9566M |
Core One Labs Inc | 6.924M |
Nova Mentis Life Science Corp | 0.7895M |
Nanosphere Health Sciences Inc | 0.4221M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -7.775M |
Revenue (Quarterly) | 19.87M |
Total Expenses (Quarterly) | 22.64M |
EPS Diluted (Quarterly) | -0.2463 |
Gross Profit Margin (Quarterly) | 84.14% |
Profit Margin (Quarterly) | -39.13% |
Earnings Yield | -27.75% |
Normalized Earnings Yield | -23.73 |